Navigation Links
Emageon Selects Jefferies & Company and SunTrust Robinson Humphrey as Advisors
Date:7/11/2008

BIRMINGHAM, Ala., July 11 /PRNewswire-FirstCall/ -- Emageon Inc. (Nasdaq: EMAG), a leader in enterprise medical information technology systems for hospitals, healthcare networks and imaging facilities, announced today that the Strategic Alternatives Committee of its Board of Directors has selected Jefferies and Company as Lead Advisor and SunTrust Robinson Humphrey as Co-Advisor to assist the committee as it evaluates all strategic options available to the company.

About Emageon Inc.

Emageon provides information technology systems for hospitals, healthcare networks and imaging facilities. Its enterprise family of solutions includes RadSuite(TM), HeartSuite(TM) and other specialty suites. All Emageon solutions are built on a unified Enterprise Content Management system offering advanced visualization and infrastructure tools for the clinical analysis and management of digital medical images, reports and associated clinical content. Emageon's standards-based solutions are designed to help customers enhance patient care, automate workflow, lower costs, improve productivity and provide better service to physicians. For more information, please visit http://www.emageon.com.


'/>"/>
SOURCE Emageon Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Emageon to Present at the Jefferies 2nd Annual Healthcare Conference
2. Emageon Inc. to Host First Quarter 2008 Financial Results Conference Call May 12, 2008
3. Emageon Receives Best in KLAS Cardiology PACS Award
4. Emageon to Present at Raymond James 29th Annual Institutional Investors Conference
5. Emageon Reports Fourth Quarter and 2007 Financial Results
6. Emageon Inc. to Host Fourth Quarter 2007 Financial Results Conference Call February 21, 2008
7. Foundation Radiology Group Formalizes Strategic Partnership with Emageon to Provide Advanced Imaging Software to Facilitate Industry-Leading Turnaround and Patient Care Response Times
8. Emageon to Present at the 26th Annual JPMorgan Healthcare Conference
9. Emageon Names Chris E. Perkins as Chief Operating Officer
10. Emageon Reports Third Quarter 2007 Financial Results
11. MedInsights, Inc. Selects Douglas Young as VP - Sales & Product Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/23/2017)... ... April 23, 2017 , ... Altura Communication Solutions, ... of Cisco Select certification and SMB specialization. Altura is now qualified to ... In earning the Select Certification, Altura fulfilled the training and exam requirements for ...
(Date:4/22/2017)... White Plains, NY (PRWEB) , ... April 22, ... ... Quarterly Report, which shows that U.S. consumers can save an average of 70% ... Even greater savings (up to 97%) are available when purchasing from other countries. ...
(Date:4/21/2017)... ... April 21, 2017 , ... An April 10 article ... ancient teeth, which reveal a great deal about prehistoric ice-age dental practitioners and their ... have been used to remove decayed dental matter, and that teeth were then filled ...
(Date:4/21/2017)... ... 21, 2017 , ... Contrary to popular perception, a new ... at noteworthy rates. Between 2002 and 2014, Salas-Wright and his colleagues found a ... the United States. The study, Trends in Fighting and Violence Among Adolescents ...
(Date:4/21/2017)... ... ... Brady (NYSE:BRC), a global leader in industrial and safety printing ... vinyl label materials received certification for the BS5609 British Marine Standard. This internationally recognized ... for use on chemical drums shipped by sea. , ÔÇťAchieving BS5609 certification ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017 ... "Global Biosimilar Pipeline and Market Prospects: Addressing Production ... report to their offering. ... "Global Biosimilar Pipeline and Market Prospects: ... Design" provides an in-depth assessment of the current trends ...
(Date:4/20/2017)...  AbbVie (NYSE: ABBV), a global biopharmaceutical company, ... hepatitis C virus (HCV) infected patients with genotype ... cirrhosis (Child-Pugh A) achieved sustained virologic response at ... investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high ... weeks of G/P treatment without ribavirin. Patients with ...
(Date:4/19/2017)... Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), announces that it will ... at the Sheraton Hotel in Toronto, Ontario . ... Company is scheduled to present on Tuesday, May 2 at 10:00 ... of the Board, Tony Holler will also attend the ... For more details about ...
Breaking Medicine Technology: